Carol Tevi-Benissan

TL;DR: A review of the worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and over time and identifies the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection.

TL;DR: The burden of IMD in different countries is summarized and the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection are identified.

TL;DR: MenAfriVac introduction has led to substantial reductions in the incidence of suspected meningitis and epidemic risk, and a substantial effect on confirmed group A meningococcalMeningitis.

TL;DR: The 59% of countries reporting that they had policies are wealthier, use more new or under-utilized vaccines, and have stronger immunization systems, according to the 2014 revision of the JRF, which permitted a global assessment of national influenza immunization policies.

TL;DR: Overall, substantial progress has been made in the region, however, countries need to improve HepB3 coverage and some countries might need to consider introducing the HepB-BD to help achieve the regional hepatitis B control goal of < 2% HBsAg prevalence among children < 5 years old by 2020.